Literature DB >> 18155448

Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls.

Jerome Brunelin1, Thierry d'Amato, Jim van Os, Alain Cochet, Marie-Françoise Suaud-Chagny, Mohamed Saoud.   

Abstract

A genetically mediated abnormal sensitivity to stress is thought to play a role in the onset, exacerbation and relapse of schizophrenia. In a double blind, placebo-controlled crossover study, peak increases in plasma ACTH (Delta ACTH) and homovanillic-acid, a dopamine metabolite, (Delta HVA) following exposure to a metabolic stressor(2DG) were studied in unaffected siblings of patients with schizophrenia (n=15), their patient relatives (n=15) and healthy controls (n=14). Siblings showed a stress response (both Delta ACTH and Delta HVA) that was significantly greater compared to controls and significantly less pronounced compared to patients. The results suggest that the genetic risk for schizophrenia may be characterized by an enhanced sensitivity to stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155448     DOI: 10.1016/j.schres.2007.11.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  21 in total

1.  Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: a sibling study using tractography-based analysis of the whole brain.

Authors:  Chen-Hao Wu; Tzung-Jeng Hwang; Yu-Jen Chen; Yun-Chin Hsu; Yu-Chun Lo; Chih-Min Liu; Hai-Gwo Hwu; Chen-Chung Liu; Ming H Hsieh; Yi Ling Chien; Chung-Ming Chen; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2014-11-04       Impact factor: 5.038

Review 2.  Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.

Authors:  Ruud van Winkel; Nicholas C Stefanis; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

3.  Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors:  Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-19       Impact factor: 5.270

4.  Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats.

Authors:  Naila Rasheed; Ausaf Ahmad; Chandra Prakash Pandey; Rajnish Kumar Chaturvedi; Mohtashim Lohani; Gautam Palit
Journal:  Neurochem Res       Date:  2009-07-01       Impact factor: 3.996

5.  Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.

Authors:  YongXin Hao; Aref Shabanpoor; Gerlinde A Metz
Journal:  Neurosci Lett       Date:  2017-05-01       Impact factor: 3.046

Review 6.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

7.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 8.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

Review 9.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

10.  Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia.

Authors:  Karl-Jürgen Bär; Sandy Berger; Maria Metzner; Michael K Boettger; Steffen Schulz; Chaitra T Ramachandraiah; Janneke Terhaar; Andreas Voss; Vikram K Yeragani; Heinrich Sauer
Journal:  Schizophr Bull       Date:  2009-04-14       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.